NYSE:OGEN

Oragenics Stock News

Healthcare > Biotechnology

Buy OGEN

*Your capital is at risk

$0.610

+0 (+0%)

At Close: Jun 03, 2026

60 Biggest Movers From Yesterday

12:00am, Tuesday, 19'th Mar 2019

Oragenics shares are trading higher after the company announced it has enrolled the 60th patient in its Phase 2 double-blind for its clinical trial of AG013.

12:00am, Monday, 18'th Mar 2019

Oragenics, Inc. Announces Enrollment Of 60th Patient In Clinical Trial

12:00am, Friday, 15'th Mar 2019

Oragenics shares are trading higher after the company announced publication of a preclinical study using its OG716, in a peer reviewed journal.

12:00am, Monday, 28'th Jan 2019

Biotech Outlook 2019: Will the Pressure Continue? | INN

07:30am, Thursday, 20'th Dec 2018

With 2018 coming to an end, what's the biotech outlook? Next year will bring new investing opportunities for those in the space.

Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Dec. 3, 2018

12:00am, Monday, 03'rd Dec 2018

Benzinga Pro's Top 10 Most-Searched Tickers For Fri., Nov. 30, 2018

12:00am, Friday, 30'th Nov 2018

Oragenics, Inc. Receives Clearance To Enroll Germany And UK Patients Into Phase 2 Clinical Trial Of AG013 For Oral Mucositis

12:00am, Thursday, 15'th Nov 2018

Oragenics reports Q3 results

12:00am, Wednesday, 14'th Nov 2018

46 Biggest Movers From Yesterday

12:00am, Thursday, 18'th Oct 2018

10 Hottest Stocks From October 17, 2018

12:00am, Wednesday, 17'th Oct 2018

55 Biggest Movers From Yesterday

12:00am, Thursday, 04'th Oct 2018

Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Wed., Oct. 3, 2018

12:00am, Wednesday, 03'rd Oct 2018

7 Stocks Moving In Tuesday's After-Hours Session

12:00am, Tuesday, 02'nd Oct 2018

Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Oct. 1, 2018

12:00am, Monday, 01'st Oct 2018

Oragenics Stock News

60 Biggest Movers From Yesterday

Oragenics shares are trading higher after the company announced it has enrolled the 60th patient in its Phase 2 double-blind for its clinical trial of AG013.

Oragenics, Inc. Announces Enrollment Of 60th Patient In Clinical Trial

Oragenics shares are trading higher after the company announced publication of a preclinical study using its OG716, in a peer reviewed journal.

Biotech Outlook 2019: Will the Pressure Continue? | INN

Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Dec. 3, 2018

Benzinga Pro's Top 10 Most-Searched Tickers For Fri., Nov. 30, 2018

Oragenics, Inc. Receives Clearance To Enroll Germany And UK Patients Into Phase 2 Clinical Trial Of AG013 For Oral Mucositis

Oragenics reports Q3 results

46 Biggest Movers From Yesterday

10 Hottest Stocks From October 17, 2018

55 Biggest Movers From Yesterday

Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Wed., Oct. 3, 2018

7 Stocks Moving In Tuesday's After-Hours Session

Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Oct. 1, 2018

Top Fintech Company